Shared molecular signatures between systemic lupus erythematosus and osteoporosis

被引:0
作者
Yuan, Xin [1 ]
Zheng, Ze-mao [2 ]
Lai, Weinan [1 ]
机构
[1] Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou
[2] Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangdong, Guangzhou
关键词
bioinformatics; gene signatures; interferon signaling; osteoporosis; systemic lupus erythematosus;
D O I
10.1002/tox.24313
中图分类号
学科分类号
摘要
This study explores the molecular interplay between systemic lupus erythematosus (SLE) and osteoporosis (OP), aiming to uncover shared gene signatures and pathways for better treatment approaches. Leveraging microarray data from the Gene Expression Omnibus (GEO) database, we employed weighted gene coexpression network analysis to identify coexpression modules in SLE and OP, with subsequent protein–protein interaction analysis clarifying the connections among shared genes. Key genes were pinpointed using CytoHubba and random forest algorithms, validated across independent GEO datasets, and further analyzed through gene set enrichment analysis (GSEA) and immune infiltration studies. We discovered two highly correlated modules in SLE and OP, isolating 30 shared genes and identifying GBP1, SOCS1, IFI16, and XAF1 as central to both conditions. Notably, XAF1 and GBP1 mRNA levels were significantly elevated in the peripheral blood of SLE patients compared with healthy and RA counterparts, underscoring their potential as biomarkers. GSEA and immune infiltration analyses indicated pronounced immune and inflammatory responses, especially in interferon signaling pathways, implicating these core-shared gene networks in the diseases' pathogenesis. The findings highlight the involvement of GBP1, SOCS1, IFI16, and XAF1 in SLE with concurrent OP and suggest that targeting immune and inflammatory responses, particularly through interferon pathways, may offer therapeutic promise for these intertwined conditions. © 2024 Wiley Periodicals LLC.
引用
收藏
页码:4744 / 4753
页数:9
相关论文
共 28 条
  • [1] Justiz Vaillant A.A., Goyal A., Varacallo M., Systemic Lupus Erythematosus. StatPearls. Treasure Island (FL) with ineligible companies. Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies, Disclosure: Matthew Varacallo declares no relevant financial relationships with ineligible companies: StatPearls Publishing Copyright © 2023, (2023)
  • [2] Kiriakidou M., Ching C.L., Systemic Lupus Erythematosus, Ann Intern Med, 172, 11, (2020)
  • [3] Fanouriakis A., Tziolos N., Bertsias G., Boumpas D.T., Update οn the diagnosis and management of systemic lupus erythematosus, Ann Rheum Dis, 80, 1, pp. 14-25, (2021)
  • [4] Zucchi D., Silvagni E., Elefante E., Et al., Systemic lupus erythematosus: one year in review 2023, Clin Exp Rheumatol, 41, 5, pp. 997-1008, (2023)
  • [5] McKeon K.P., Jiang S.H., Treatment of systemic lupus erythematosus, Aust prescr, 43, 3, pp. 85-90, (2020)
  • [6] Robertson J.M., James J.A., Preclinical systemic lupus erythematosus, Rheum Dis Clin North Am, 40, 4, pp. 621-635, (2014)
  • [7] Fasano S., Milone A., Nicoletti G.F., Isenberg D.A., Ciccia F., Precision medicine in systemic lupus erythematosus, Nat Rev Rheumatol, 19, 6, pp. 331-342, (2023)
  • [8] Kimball J.S., Johnson J.P., Carlson D.A., Oxidative stress and osteoporosis, J bone jt Surg, 103, 15, pp. 1451-1461, (2021)
  • [9] Munoz M., Robinson K., Shibli-Rahhal A., Bone health and osteoporosis prevention and treatment, Clin Obstet Gynecol, 63, 4, pp. 770-787, (2020)
  • [10] Gielen E., Dupont J., Dejaeger M., Laurent M.R., Sarcopenia, osteoporosis and frailty, Metabolism, 145, (2023)